Pluristem Therapeutics Inc. (NASDAQ: PSTI) Must Gain 75.17% To Achieve Consensus Price Target
Pluristem Therapeutics Inc. (NASDAQ:PSTI) has a beta value of 2.12 and has seen 29.66 million shares traded in the recent trading session. The company, currently valued at $45.60M, closed the recent trade at $1.78 per share which meant it gained $0.31 on the day or 21.08% during that session. The PS